Patents expiring in 2038

US 9861621

LPT-723 and immune checkpoint inhibitor combinations and methods of treatment

Biomed Valley Discoveries, Inc. · Granted Tue Jan 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9861691

Norovirus vaccine formulations

Takeda Vaccines, Inc. · Granted Tue Jan 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9861681

Therapeutic compositions for neutralizing type I interferons, and methods of use

The United States of America as represented by the Secretary of the Army, on behalf of the United States Army Medical Research Institute of Infectious Diseases · Granted Tue Jan 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9862928

Generation of natural killer cells and lymphoid tissue inducer-like (LTi-like) NK-22 cells

Regents of the University of Minnesota · Granted Tue Jan 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9862679

Potent and selective inhibitors of monoamine transporters; method of making; and use thereof

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Tue Jan 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9862724

Pyrazolo[1,5-a]pyrimidine-based compounds, compositions comprising them, and methods of their use

LEXICON PHARMACEUTICALS, INC. · Granted Tue Jan 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9862946

Peptide oligonucleotide conjugates

Sarepta Therapeutics, Inc. · Granted Tue Jan 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9861617

Compositions of 1,2,4-oxadiazole benzoic acid compounds and methods for their use

PTC THERAPEUTICS, INC. · Granted Tue Jan 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9861600

Methods and compositions for treating and identifying compounds to treat age-related macular degeneration treatment

Arizona Board of Regents, A Body Corporate Of The State Of Arizona Acting For An On Behalf Of The University of Arizona · Granted Tue Jan 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9861683

Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

Rani Therapeutics, LLC · Granted Tue Jan 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9862708

Pyrazolone compounds and uses thereof

TEMPEST THERAPEUTICS, INC. · Granted Tue Jan 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9862684

Modulation of K2P channels

The Regents of the University of California · Granted Tue Jan 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9862693

Compounds and methods of treating cancer

The Regents of the University of California · Granted Tue Jan 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9861695

Stable aqueous formulations of adalimumab

Coherus BioSciences, Inc. · Granted Tue Jan 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9862746

Compositions and methods relating to hindering DOT1L recruitment by MLL-fusion proteins

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jan 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9861705

Conjugates of an IL-2 moiety and a polymer

Nektar Therapeutics · Granted Tue Jan 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9861590

Self-supporting films for delivery of therapeutic agents

Covidien LP · Granted Tue Jan 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9861606

Therapeutic for treating inflammatory lung disorders

University College Cardiff Consultants Limited · Granted Tue Jan 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9862748

Peptide compounds and methods of production and use thereof

The Board of Regents of the University of Oklahoma · Granted Tue Jan 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9862761

Composition and method for preventing or treating a tauopathy

Northwestern University · Granted Tue Jan 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9861614

Nuclear transport modulators and uses thereof

Karyopharm Therapeutics Inc. · Granted Tue Jan 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9861515

Compositions and methods relating to an occlusive polymer hydrogel

Revolution Contraceptives LLC · Granted Tue Jan 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 3025863

COMPOSE PHARMACEUTIQUE CONTENANT DU CEFUROXIME

ACRAF [IT] · Granted Thu Jan 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Jan 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9867876

Parenteral norovirus vaccine formulations

Takeda Vaccines, Inc. · Granted Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9868706

Processes for the preparation of uracil derivatives

Neurocrine Biosciences, Inc. · Granted Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9868769

Mutated Salmonella enteriaca

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9867880

Cured oil-hydrogel biomaterial compositions for controlled drug delivery

ATRIUM MEDICAL CORPORATION · Granted Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9867795

Nitrated lipids and methods of making and using thereof

University College Cardiff Consultants Limited · Granted Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9867785

Methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells

EnGeneIC Molecular Delivery Pty Ltd · Granted Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9868777

CMV neutralizing antigen binding proteins

The Board of Regents of the University of Texas System · Granted Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9868961

Methods and compositions for localized secretion of anti-CTLA-4 antibodies

The Regents of the University of California · Granted Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9868774

Anti-CD22 chimeric antigen receptors

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9867856

Phospholipid compositions and their preparation

AKER BIOMARINE ANTARCTIC AS · Granted Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9868950

Lipid formulated compositions and methods for inhibiting expression of serum amyloid A gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9867873

Factor IX polypeptides and methods of use thereof

BIOVERATIV THERAPEUTICS INC. · Granted Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9867882

Carbohydrate conjugates as delivery agents for oligonucleotides

Alnylam Pharmaceuticals, Inc. · Granted Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9868949

Organic compositions to treat EPAS1-related diseases

Arrowhead Pharmaceuticals, Inc. · Granted Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9867846

Atopic-dermatitis-suppressing fiber, fiber assembly and fiber product, method for using same, and method for suppressing atopic dermatitis

Kurashiki Boseki Kabushiki Kaisha · Granted Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9868943

Enhanced staphylolytic activity of the Staphylococcus aureus bacteriophage vB—SauS-philPLA88 virion-associated peptidoglycan hydrolase HydH5: fusions, deletions and synergy with LysH5

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9867830

Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic pain

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9868725

Isoindoline-1-one derivatives as cholinergic muscarinic M1 receptor positive alloesteric modulator activity for the treatment of Alzheimer's disease

Takeda Pharmaceutical Company Limited · Granted Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9867866

Methods for diagnosing, prognosing and treating muscular dystrophy

BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE OF THE UNIVERSITY OF NEVADA, RENO · Granted Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9867778

Controlled release antimicrobial compositions and methods for the treatment of otic disorders

The Regents of the University of California · Granted Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9867845

Vectors for delivery of agents across biological membranes

The Regents of the University of California · Granted Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9868698

(2S,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydroxymethyl-2-methylpentanoic acid

Theravance Biopharma R&D IP, LLC · Granted Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9868736

Deubiquitinase inhibitors and methods for use of the same

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9868954

Reduction of TGFβ signaling in myeloid cells in the treatment of cancer

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9872909

Method for enhancing specific immunotherapies in cancer treatment

Providence Health & Services—Oregon · Granted Tue Jan 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)